Company Spotlight – Precede Bio
Precede Biosciences is embracing comprehensive epigenomics to help drive personalized medicine.
Precede Biosciences is embracing comprehensive epigenomics to help drive personalized medicine.
Lightcast controls microdroplets with light to create a fast, flexible experimental platform.
Tagomics, developers of a cutting-edge platform for comprehensive disease insight and diagnosis, today announces a £6.7m funding round.
Stilla Technologies, the start-up leading innovations in digital PCR, announced it has closed a $26.5 million Series C financing.
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.